Cover Image
Market Research Report
Product code 
661014

Europe Molecular Biosensors Market - Segmented by Application, Technology, Type, and Geography - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

Published: | Mordor Intelligence Pvt Ltd | 78 Pages | Delivery time: 2-3 business days

Price

Back to Top
Europe Molecular Biosensors Market - Segmented by Application, Technology, Type, and Geography - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
Published: January 17, 2022
Mordor Intelligence Pvt Ltd
Content info: 78 Pages
Delivery time: 2-3 business days
  • Description
  • Table of Contents

The Europe Molecular Biosensors Market is expected to register a CAGR of 5.9% during the forecast period. A molecular biosensor is a device that uses specific biochemical reactions mediated by isolated enzymes, immunosystems, tissues, organelles, or whole cells to detect chemical compounds usually by electrical, thermal, or optical signals. Molecular biosensors are, thus, able to facilitate rapid detection and diagnosis at the POC, which make them particularly useful for an early and unequivocal diagnosis, and to prevent further disease spread.

In Europe, due to the increasing prevalence of chronic diseases, demand for point-of-care diagnostics has increased. This has led to an increase in demand for molecular biosensors. According to the International Diabetes Federation, in 2019, Germany had the highest prevalence of diabetes among the adult population in Europe with 15.3 percent of people with diabetes, followed by Portugal with 14.2 percent of people with diabetes. Thus, the above-mentioned factors have resulted in increased adoption of the molecular biosensor, which has helped the market growth.

Key Market Trends

Electrochemical Biosensors is Expected to Dominate the Market Over the Forecast Period

Electrochemical biosensors have emerged as reliable molecular sensing devices suitable for the detection of pathogens in liquid biopsies. Short assay time, simple handling, low cost, small sample requirement, and good performance in complex samples with minimal pre-treatments justify their increasing growth and suitability for point-of-care applications.

These biosensors are able to facilitate rapid detection and diagnosis at the point-of-care, which make them particularly useful for an early and unequivocal diagnosis, and to prevent further disease spread. In Europe, Methicillin-resistant Staphylococcus aureus (MRSA) infection remains an important pathogen in the European Union (EU) and European Economic Area (EEA) countries, as the levels of MRSA were high in several countries. In addition, in the EU/EEA population-weighted mean percentage for vancomycin-resistant Enterococcus faecium was increased from 10.5% in 2015 to 17.3% in 2018. Hence with an increase in infection from pathogens, the demand for fast point-of-care (POC) diagnostics like electrochemical biosensors is expected to increase in near future in Europe.

Competitive Landscape

The Europe Molecular Biosensors Market is consolidated competitive. The market players with more funds for research and better distribution system have established their position in the market. Some of the market players include Dynamic Biosensors GmbH, Abbott Laboratories Inc., Siemens Healthcare, Nova biomedical Corporation, Sysmex Corporation and Others.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support
Product Code: 60830

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Prevalence of Chronic and Lifestyle Induced Diseases
    • 4.2.2 Growing Demand for Point of Care Testing
    • 4.2.3 Increasing Application of Biosensors in Various Industries
  • 4.3 Market Restraints
    • 4.3.1 Strict Regulatory Requirements for Biosensors
    • 4.3.2 High Cost Involved in Research and Development
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Technology
    • 5.1.1 Electrochemical Biosensors
    • 5.1.2 Optical Biosensors
    • 5.1.3 Thermal Biosensors
    • 5.1.4 Others
  • 5.2 By Application
    • 5.2.1 Medical Diagnostics
    • 5.2.2 Food and Beverages
    • 5.2.3 Environment Safety
    • 5.2.4 Defense and Security
    • 5.2.5 Other Applications
  • 5.3 Geography
    • 5.3.1 Europe
      • 5.3.1.1 Germany
      • 5.3.1.2 United Kingdom
      • 5.3.1.3 France
      • 5.3.1.4 Italy
      • 5.3.1.5 Spain
      • 5.3.1.6 Rest of Europe

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Dynamic Biosensors GmbH
    • 6.1.2 Abbott Laboratories Inc.
    • 6.1.3 Siemens Healthcare
    • 6.1.4 Nova biomedical Corporation
    • 6.1.5 Sysmex Corporation
    • 6.1.6 F. Hoffmann La Roche Ltd
    • 6.1.7 Johnson and Johnson
    • 6.1.8 Biacore (GE healthcare)
    • 6.1.9 Medtronic Plc

7 MARKET OPPORTUNITIES AND FUTURE TRENDS